Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

RNA Splicing01:32

RNA Splicing

60.2K
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
60.2K
Alternative RNA Splicing02:18

Alternative RNA Splicing

24.5K
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
24.5K
Alternative RNA Splicing02:18

Alternative RNA Splicing

4.7K
4.7K
Pre-mRNA Processing: RNA Splicing01:36

Pre-mRNA Processing: RNA Splicing

6.4K
6.4K
Chromatin Structure Regulates pre-mRNA Processing02:41

Chromatin Structure Regulates pre-mRNA Processing

8.0K
In eukaryotic cells, nascent mRNA transcripts need to undergo many post-transcriptional modifications to reach the cell cytoplasm and translate into functional proteins. For a long time, transcription and pre-mRNA processing were considered two independent events that occur sequentially in the cell. However, it has now been well established that transcription and pre-mRNA processing are two simultaneous processes that are precisely regulated inside the cell.
The chromatin structure, especially...
8.0K
What is Gene Expression?01:36

What is Gene Expression?

10.5K
A gene is a stretch of DNA that serves as the blueprint for functional RNAs and proteins. Since DNA is comprised  of nucleotides and proteins are comprised of amino acids, a mediator is required to convert the information encoded in DNA into proteins. This mediator is the messenger RNA (mRNA). mRNA copies the blueprint from DNA by a process called transcription. In eukaryotes, transcription occurs in the nucleus by complementary base-pairing with the DNA template. The mRNA is then...
10.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mavacamten shows broad benefit in human and mouse models of MYBPC3-related hypertrophic cardiomyopathy.

Nature cardiovascular research·2026
Same author

Inference of fitness landscapes with heterogeneous patterns of epistasis across sites.

bioRxiv : the preprint server for biology·2026
Same author

Integrative skin-blood transcriptomic analysis identifies circulating biomarkers reflecting disease activity in atopic dermatitis.

Frontiers in allergy·2026
Same author

Mitochondria directly interact with the nuclear pore complex.

Nature·2026
Same author

A signal-responsive cooperative transcription factor network determines alveolar macrophage identity.

The Journal of experimental medicine·2026
Same author

IMPaCT-Data: A Federated Precision Medicine Infrastructure Associated with Science and Technology in Spain.

Studies in health technology and informatics·2026

Related Experiment Video

Updated: Jan 2, 2026

Identification of Alternative Splicing and Polyadenylation in RNA-seq Data
08:35

Identification of Alternative Splicing and Polyadenylation in RNA-seq Data

Published on: June 24, 2021

6.3K

dSreg: a Bayesian model to integrate changes in splicing and RNA-binding protein activity.

Carlos Martí-Gómez1, Enrique Lara-Pezzi1, Fátima Sánchez-Cabo1

  • 1Molecular Regulation of Heart Failure (CMG and ELP); Bioinformatics Unit (FSC), Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid 28029, Spain.

Bioinformatics (Oxford, England)
|December 14, 2019
PubMed
Summary

dSreg, a new Bayesian model, enhances alternative splicing (AS) analysis by integrating RNA-seq with regulatory data. It accurately identifies regulators of AS changes, improving sensitivity and specificity over traditional methods.

More Related Videos

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models
09:58

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models

Published on: December 9, 2016

14.2K
Using the E1A Minigene Tool to Study mRNA Splicing Changes
10:25

Using the E1A Minigene Tool to Study mRNA Splicing Changes

Published on: April 22, 2021

5.3K

Related Experiment Videos

Last Updated: Jan 2, 2026

Identification of Alternative Splicing and Polyadenylation in RNA-seq Data
08:35

Identification of Alternative Splicing and Polyadenylation in RNA-seq Data

Published on: June 24, 2021

6.3K
Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models
09:58

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models

Published on: December 9, 2016

14.2K
Using the E1A Minigene Tool to Study mRNA Splicing Changes
10:25

Using the E1A Minigene Tool to Study mRNA Splicing Changes

Published on: April 22, 2021

5.3K

Area of Science:

  • Genomics
  • Molecular Biology
  • Bioinformatics

Background:

  • Alternative splicing (AS) generates transcript diversity crucial for development and cellular function.
  • Dysregulation of AS is implicated in diseases like cancer and neurological disorders.
  • Current methods for inferring AS regulatory mechanisms are limited by arbitrary thresholds and error propagation.

Purpose of the Study:

  • To develop a novel Bayesian model, dSreg, for robust identification of alternative splicing regulators.
  • To integrate RNA-sequencing data with regulatory feature data, such as RNA-binding protein sites.
  • To improve the accuracy and efficiency of alternative splicing analysis.

Main Methods:

  • dSreg employs a Bayesian framework to simultaneously estimate changes in exon inclusion rates and identify key regulators of AS.
  • The model integrates RNA-sequencing data with regulatory feature data (e.g., RNA-binding protein binding sites).
  • dSreg was validated using simulated data and experimental data from RNA-binding protein knock-down experiments.

Main Results:

  • dSreg significantly improved both sensitivity and specificity in identifying AS changes, even with low RNA-seq read coverage.
  • The model outperformed traditional enrichment methods like over-representation analysis and gene set enrichment analysis.
  • dSreg demonstrated enhanced performance in analyzing knock-down experiments of RNA-binding proteins.

Conclusions:

  • dSreg offers a more sensitive and specific approach to analyzing alternative splicing regulation.
  • The model facilitates the integration of large, low-coverage RNA-seq datasets for AS analysis.
  • dSreg enables more cost-effective RNA-sequencing experiments for studying alternative splicing.